scholarly article | Q13442814 |
P2093 | author name string | Morales P | |
Cosio FG | |||
Kremers WK | |||
Fidler ME | |||
Larson TS | |||
Stegall MD | |||
Amer H | |||
Myslak M | |||
P2860 | cites work | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts | Q44048416 | ||
Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies | Q44321472 | ||
Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies | Q44854978 | ||
Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction | Q45057604 | ||
Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study | Q45195098 | ||
Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation | Q45219608 | ||
Kidney allograft fibrosis and atrophy early after living donor transplantation. | Q46427161 | ||
Sirolimus monotherapy: feasible immunosuppression for long-term follow-up of kidney transplantation--a pilot experience | Q46825342 | ||
Conversion from cyclosporine to sirolimus in stable renal transplant recipients | Q46863642 | ||
Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism | Q46903645 | ||
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus | Q46936585 | ||
The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2748-2756 | |
P577 | publication date | 2007-10-17 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Proteinuria after kidney transplantation, relationship to allograft histology and survival | |
P478 | volume | 7 |
Q90003518 | Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function |
Q91926348 | Adherence to Dietary Recommendations Measured by Smartphone-based Recipe Nutrition Calculator in Kidney Transplant Patients |
Q61455909 | Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation |
Q46560569 | Biopsies in renal transplant patients with proteinuria: histological findings. |
Q43062155 | C1q deposition in the renal allograft: a report of 24 cases |
Q38035660 | Chronic renal allograft injury: early detection, accurate diagnosis and management. |
Q41758257 | Clinical outcome in patients with chronic antibody-mediated rejection treated with and without rituximab and intravenous immunoglobulin combination therapy. |
Q51348024 | Clinical significance of proteinuria at posttransplant year 1 in kidney transplantation. |
Q92604070 | Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study |
Q51267068 | Cystatin C and albuminuria as predictors of long-term allograft outcomes in kidney transplant recipients. |
Q36105785 | Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol Biopsies. |
Q37641382 | Derivation of a Predictive Model for Graft Loss Following Acute Kidney Injury in Kidney Transplant Recipients |
Q42211166 | Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure? |
Q40219212 | EMMPRIN expression is involved in the development of interstitial fibrosis and tubular atrophy in human kidney allografts |
Q39626782 | Early inhibition of the renin-angiotensin system improves the long-term graft survival of single pediatric donor kidneys transplanted in adult recipients |
Q48242270 | Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study. |
Q46579187 | Early renal transplantation after donor renal angiography affects initial graft function |
Q51149371 | Effect and safety of Tripterygium Hypoglaucum (Lévl.) hutch in treating proteinuria of kidney transplant recipients. |
Q53425824 | Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. |
Q36393014 | Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients |
Q30427104 | Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality |
Q34426913 | Elevated urine heparanase levels are associated with proteinuria and decreased renal allograft function |
Q43075774 | Evaluation of protocol biopsy utility 12 months after renal transplantation: a multicenter observational analysis. |
Q45351621 | Five-year outcomes in living donor kidney transplants with a positive crossmatch. |
Q41699696 | High-grade proteinuria as a cardiovascular risk factor in renal transplant recipients |
Q37964270 | Histology and proteinuria after renal transplantation |
Q37764468 | Hypertension in the kidney transplant recipient. |
Q37535280 | Identification and characterization of kidney transplants with good glomerular filtration rate at 1 year but subsequent progressive loss of renal function |
Q46351643 | Increase in proteinuria after acute kidney graft rejection is associated with decreased graft function and survival |
Q51014736 | Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients. |
Q52861006 | Living Donor Transplantation: Long-Term Evolution Related to Age Matching. |
Q91301304 | Long-term Trends in the Clinicopathologic Features of Kidney Transplant Recipients With Graft Dysfunction |
Q33871255 | Long-term graft function changes in kidney transplant recipients |
Q37964274 | Management of proteinuria in clinical practice after kidney transplantation. |
Q38243597 | Management of proteinuria in the transplanted patient |
Q37964269 | Mechanisms and risk factors for the development of the proteinuria after kidney transplantation. |
Q38812339 | Nephrotic Range Proteinuria in Renal Transplantation: Clinical and Histologic Correlates in a 10-year Retrospective Study. |
Q37964276 | New options and perspectives for proteinuria management after kidney transplantation. |
Q43251594 | Nonalbumin proteinuria in islet transplant recipients |
Q35550544 | Paricalcitol for secondary hyperparathyroidism in renal transplantation |
Q36203830 | Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis |
Q90066192 | Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study |
Q43829027 | Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death |
Q52668909 | Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. |
Q51805170 | Profiling proteinuria in children after renal transplantation. |
Q41039243 | Prognostic Significance of 1-Year Serum Albumin Levels Within the Normal Range After Kidney Transplantation |
Q37964273 | Prognostic significance and diagnosis of proteinuria in renal transplantation |
Q40997354 | Proteinuria 1 year after renal transplantation is associated with impaired graft survival in children |
Q38012182 | Proteinuria after kidney transplantation |
Q34483895 | Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study |
Q47830873 | Proteinuria in pediatric renal transplant recipients. |
Q38129623 | Recurrence of glomerulonephritis after renal transplantation. |
Q51278524 | Relationship Between Albuminuria During the First Year and Antibody-Mediated Rejection in Protocol Biopsies in Kidney Transplant Recipients. |
Q91611032 | Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age |
Q52845695 | Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. |
Q89029597 | Renal Doppler Resistance Indices in Kidney Transplant Recipients With Proteinuria |
Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
Q51273191 | Resolution of low-grade proteinuria is associated with improved outcomes after renal transplantation-a retrospective longitudinal study. |
Q44658058 | The effect of everolimus versus mycophenolate upon proteinuria following kidney transplant and relationship to graft outcomes |
Q34269169 | The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria |
Q41696181 | Time-varying maximal proteinuria correlates with adverse cardiovascular events and graft failure in kidney transplant recipients |
Q46225652 | Transplantation: Proteinuria in kidney transplantation: an ongoing story |
Q37452790 | Urinary retinol binding protein is a marker of the extent of interstitial kidney fibrosis |
Q36640019 | Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival |
Q43284034 | Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival |
Search more.